ANTH

Anthera Pharmaceuticals, Inc. Competitors

$1.65
*  
0.07
4.07%
Get ANTH Alerts
*Delayed - data as of Sep. 18, 2014 13:55 ET  -  Find a broker to begin trading ANTH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ANTH Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

Anthera Pharmaceuticals, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Prana Biotechnology Ltd
PRAN: NASDAQ-CM
$ 2.1996 -0.03 ▼ 478,323 $ 2.29
$ 2.19
$ 13.29
$ 1.47
NE 89,772,275
Prestige Brand Holdings, Inc.
PBH: NYSE
$ 32.41 0.02 ▲ 54,192 $ 32.57
$ 32.17
$ 36.69
$ 24.94
24.74 1,684,380,110
Prima BioMed Ltd
PBMD: NASDAQ-GM
$ 1.04 0.01 ▲ 31,872 $ 1.08
$ 1.03
$ 1.95
$ .82
NE 36,956,400
Progenics Pharmaceuticals Inc.
PGNX: NASDAQ-GS
$ 5.22 -0.10 ▼ 442,315 $ 5.4199
$ 5.22
$ 7.45
$ 3.1001
NE 363,082,320
ProPhase Labs, Inc.
PRPH: NASDAQ-GM
$ 1.42 unch 16,233 $ 1.47
$ 1.40
$ 2.98
$ 1.35
NE 27,404,580
Prosensa Holding N.V.
RNA: NASDAQ-GS
$ 8.57 -0.09 ▼ 73,828 $ 9.01
$ 8.315
$ 24.10
$ 3.431
NE 307,945,810
Prothena Corporation plc
PRTA: NASDAQ-GS
$ 23.03 -0.60 ▼ 57,386 $ 23.72
$ 22.97
$ 49.24
$ 16.71
NE 630,262,010
Provectus Biopharmaceuticals, Inc.
PVCT: AMEX
$ 1.04 -0.02 ▼ 1,697,620 $ 1.11
$ 1.02
$ 3.75
$ .30
NE 183,703,520
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 40.45 2.07 ▲ 296,060 $ 40.67
$ 38.21
$ 38.55
$ 13.15
NE 1,216,493,300
Puma Biotechnology Inc
PBYI: NYSE
$ 274.54 2.19 ▲ 51,388 $ 275.9973
$ 271.8538
$ 279.37
$ 33.70
NE 8,268,595,720
QLT Inc.
QLTI: NASDAQ-GS
$ 5.205 -0.19 ▼ 156,780 $ 5.4452
$ 5.13
$ 7.10
$ 4.16
NE 265,881,810
Raptor Pharmaceutical Corp.
RPTP: NASDAQ-GM
$ 10.89 -0.10 ▼ 154,577 $ 11.32
$ 10.73
$ 17.72
$ 7.12
NE 681,899,130
Receptos, Inc.
RCPT: NASDAQ-GS
$ 62.63 -0.33 ▼ 249,768 $ 63.7699
$ 62.01
$ 65.47
$ 20.90
NE 1,666,646,930
Recro Pharma, Inc.
REPH: NASDAQ-CM
$ 3.30 -0.10 ▼ 39,525 $ 3.40
$ 3.25
$ 9.88
$ 2.88
NE 25,436,400
Redhill Biopharma Ltd.
RDHL: NASDAQ-CM
$ 13.35 -0.85 ▼ 695 $ 13.415
$ 13.35
$ 21
$ 9.01
NE 116,745,750
Regado BioSciences, Inc.
RGDO: NASDAQ-CM
$ 1.03 -0.02 ▼ 732,735 $ 1.08
$ 1.02
$ 14.10
$ 1.01
NE 34,617,270
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 362 2.90 ▲ 331,828 $ 362.8199
$ 357.25
$ 369.31
$ 257.69
103.13 35,794,560,000
Regulus Therapeutics Inc.
RGLS: NASDAQ-GM
$ 7.38 -0.03 ▼ 23,849 $ 7.63
$ 7.33
$ 11.88
$ 5.404
NE 319,974,660
Reliv' International, Inc.
RELV: NASDAQ-GS
$ 1.2399 0.02 ▲ 348 $ 1.2399
$ 1.21
$ 3.50
$ 1.14
41.33 15,704,573
Relypsa, Inc.
RLYP: NASDAQ-GS
$ 25.10 0.31 ▲ 44,406 $ 25.16
$ 24.62
$ 52.74
$ 11.55
NE 849,509,500
Retrophin, Inc.
RTRX: NASDAQ-GM
$ 11.995 0.54 ▲ 354,366 $ 12.25
$ 11.3001
$ 24.25
$ 9.09
NE 320,050,590
Revance Therapeutics, Inc.
RVNC: NASDAQ-GM
$ 21.56 -0.02 ▼ 43,405 $ 22.045
$ 21.50
$ 39.86
$ 20.11
NE 506,509,080
Rexahn Pharmaceuticals, Inc.
RNN: AMEX
$ .7669 0.01 ▲ 586,896 $ .80
$ .76
$ 1.85
$ .37
NE 136,702,226
Rigel Pharmaceuticals, Inc.
RIGL: NASDAQ-GS
$ 2.20 unch 503,717 $ 2.248
$ 2.145
$ 5
$ 2.12
NE 192,568,200
Rosetta Genomics Ltd.
ROSG: NASDAQ-CM
$ 3.7599 -0.15 ▼ 232,961 $ 4.2032
$ 3.69
$ 6.69
$ 2.35
NE 9,625,344